Bad Mergentheim-Edelfingen, Germany

Michael Braun

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael Braun: Innovator in Biochemical Engineering

Introduction

Michael Braun is a notable inventor based in Bad Mergentheim-Edelfingen, Germany. He has made significant contributions to the field of biochemical engineering, particularly in the development of enzyme mutants for pharmaceutical applications. With a total of three patents to his name, Braun's work has the potential to impact the production of important compounds in medicine.

Latest Patents

Braun's latest patents include innovations related to 7β-hydroxysteroid dehydrogenase mutants and processes for the preparation of ursodeoxycholic acid. The first patent describes a nucleic acid molecule that encodes a 7β-hydroxysteroid dehydrogenase (7β-HSDH) mutant. This mutant is designed to catalyze the stereospecific enzymatic reduction of a 7-ketosteroid to the corresponding 7-hydroxysteroid. The mutant exhibits decreased substrate inhibition and altered cofactor usage compared to the wildtype 7β-HSDH. The second patent focuses on novel 7β-hydroxysteroid dehydrogenase mutants and their use in enzymatic reactions involving cholic acid compounds, particularly in the synthesis of ursodeoxycholic acid (UDCS) using recombinant microorganisms.

Career Highlights

Michael Braun is currently employed at Pharmazell GmbH, where he continues to advance his research in enzyme technology. His work is pivotal in enhancing the efficiency of biochemical processes, which can lead to more effective pharmaceutical products. Braun's innovative approach to enzyme modification has garnered attention in the scientific community.

Collaborations

Braun collaborates with esteemed colleagues such as Arno Aigner and Dirk Weuster-Botz. These partnerships enhance the research and development efforts at Pharmazell GmbH, fostering an environment of innovation and scientific discovery.

Conclusion

Michael Braun is a distinguished inventor whose work in enzyme technology is shaping the future of pharmaceutical manufacturing. His patents reflect a commitment to advancing biochemical processes that can lead to significant medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…